AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the 29th day of September, 2019, by and among Health Sciences Acquisitions Corporation, a Delaware corporation (the “Company”), and the undersigned parties listed under Investor on the signature page hereto (each, an “Investor” and collectively, the “Investors”).
IMMUNOVANT, INC. INDEMNITY AGREEMENTIndemnity Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • Delaware
THIS INDEMNITY AGREEMENT (the “Agreement”) is made and entered into as of [ ], 20[ ] between Immunovant, Inc., a Delaware corporation (the “Company”), and [ ] (the “Indemnitee”).
IMMUNOVANT, INC. EMPLOYMENT AGREEMENTEmployment Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
This Employment Agreement (this “Agreement”) is entered into as of April 15, 2019, by and between W. Bradford Middlekauff (the “Executive”) and Immunovant, Inc. (the “Company”).
AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT by and among IMMUNOVANT SCIENCES LTD. AND ROIVANT SCIENCES LTD. Dated as of December 28, 2018Sharing and Cooperation Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
This AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT (this “Agreement”), dated as of December 28, 2018 (the “Effective Date”), is entered into by and among Immunovant Sciences Ltd., a Bermuda exempted limited company (the “Company”), Roivant Sciences Ltd., a Bermuda exempted limited company (“Roivant”), and the Persons who from time to time become Shareholders of the Company in accordance with this Agreement and execute and deliver a Joinder Agreement, substantially as set forth on Exhibit A (a “Joinder Agreement”), (with each of the Company, Roivant and such Persons, individually, a “Party” and together, the “Parties”).
SERVICES AGREEMENTServices Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
This Services Agreement (the “Agreement”) is entered into effective as of August 20, 2018, by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (the “Service Provider”), Immunovant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“ISG”), Immunovant, Inc., a corporation organized under the laws of the State of Delaware (“II”), and Immunovant Sciences Ltd., an exempted limited company organized under the laws of Bermuda (“ISL”, and together with ISG and II, and any Additional Service Recipient the “Service Recipients” and each a “Service Recipient”).
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Assignment and Assumption Agreement”) is made and entered into as of December 7, 2018 (the Effective Date”), by and between Immunovant Sciences GmbH, a company organized and existing pursuant to the laws of Switzerland having a principal place of business at Viaduktstrasse 8, Basel 4051, Switzerland (“ISG”) and Roivant Sciences GmbH, a company organized and existing pursuant to the laws of Switzerland having a principal place of business at Viaduktstrasse 8, Basel 4051, Switzerland (“RSG”).
RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
This Restricted Stock Agreement (this “Agreement”) is entered into as of the 29th day of September, 2019, by and between Health Sciences Acquisitions Corporation, a Delaware corporation (the “Company”), and Health Sciences Holdings, LLC (the “Holder”).
LICENSE AGREEMENTLicense Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
